Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Head and Neck Cancer

 

SGX942 for Oral Mucositis in Patients With Head and Neck Cancer (20131334)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating, Multicenter Study Of SGX942 For The Attenuation Of Oral Mucositis In Patients Being Treated With Concomitant Chemoradiation (CRT) For The Treatment Of Squamous Cell Carcinoma Of The Head And Neck

Investigator: Jay Liao, MD;   Conditions: Head & Neck Cancer;    Status: Recruiting;   Study ID: NCT02013050